H.C

Business

DURECT Corporation to Present at the H.C. Wainwright Global Investment Conference By Investing.com

CUPERTINO, Calif., Sept. 4, 2024 /PRNewswire/ — DURECT Corporation (Nasdaq: DRRX), a late-stage biopharmaceutical company pioneering the development of epigenetic…

Read More »
Back to top button